ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 295641 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 295641; 2) Community: the network communities that were significantly associated with the response to NSC 295641; 3) Molecule: the relationships between components within communities and NSC 295641; 4) MDR: the compounds that were significantly associated with the NSC 295641.

NSC Compound Enrichment Correlation
NSC 603086 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (Z)- 0.0462077035966084 0.36388308
NSC 617823 4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride 0.0462077035966084 0.28702041
NSC 619102 4-Methoxy-1,5-benzothiazepine-1,1-dioxide 0.0462077035966084 0.18668754
NSC 623639 Cyclopentane-1,3-dimethanamine, N,N,N,N',N',N'-hexamethyl-2-oxo-, iodide 0.0462077035966084 0.35456074
NSC 627744 Null 0.0462077035966084 0.16459811
NSC 636009 Crotoxin CD 0.0462077035966084 -0.35526732
NSC 638634 4-Piperidinone, 3,5-bis(phenylmethylene)-1-(1-oxo-3-phenyl- 2-propenyl)- 0.0462077035966084 0.26696531
NSC 638748 Tetrakis(8-chinolineolato)titanium(IV)-tetrahydrochloride 0.0462077035966084 0.27288374
NSC 639187 Landomycin A 0.0462077035966084 0.20139084
NSC 639981 Null 0.0462077035966084 0.34194856
Total:104  Current:98    [First] [Prev] [Next] [Last]